IBT

International Biotechnology Trust Portfolio holdings

AUM $297M
1-Year Est. Return 17.25%
This Quarter Est. Return
1 Year Est. Return
+17.25%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$219M
AUM Growth
-$58.2M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
71
New
Increased
Reduced
Closed

Top Buys

1 +$7.63M
2 +$6.9M
3 +$5.9M
4
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$5.53M
5
LLY icon
Eli Lilly
LLY
+$2.77M

Top Sells

1 +$10.8M
2 +$10.3M
3 +$8.32M
4
GILD icon
Gilead Sciences
GILD
+$4.18M
5
VRTX icon
Vertex Pharmaceuticals
VRTX
+$3.71M

Sector Composition

1 Healthcare 96.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
51
$505K 0.23%
849
-463
52
$498K 0.23%
9,800
-13,300
53
$352K 0.16%
+23,000
54
$298K 0.14%
9,500
-20,500
55
$183K 0.08%
5,653
56
$140K 0.06%
10,000
57
-14,000
58
-24,200
59
-220,000
60
-25,803
61
-25,000
62
-35,500
63
-28,830
64
-303,000
65
-19,953
66
-11,200
67
-11,295
68
-17,000
69
-31,723
70
-965,245
71
-30,000